Pache I, Bilodeau M
Service d'hépatologie, Centre hospitalier de l'Université de Montréal, Hôpital Saint-Luc, Montréal, Québec, Canada.
Aliment Pharmacol Ther. 2005 Mar 1;21(5):525-9. doi: 10.1111/j.1365-2036.2005.02387.x.
Bleeding is a recognized complication of abdominal paracentesis. Special concern has been raised when it is performed in patients with liver failure because of coagulation disorders and collaterals in the abdominal wall.
To assess the clinical characteristics of patients who developed haemorrhagic complications after paracentesis.
We reviewed all cases of severe haemorrhage occurring after paracentesis in patients admitted to the Liver Unit of our institution between 1994 and 2004.
Nine cases were identified among 4729 procedures. The occurrence of severe haemorrhage represented 0.19% of all procedures with a death rate of 0.016%. Bleeding was not related to operator experience, elevated international normalized ratio or low platelets. It occurred in patients with high model for end-stage liver disease and Child-Pugh scores. Furthermore, some degree of renal failure was present in all but one patient.
Severe haemorrhage after abdominal paracentesis in patients with liver disease occurs in 0.2% of cases. It occurs in patients with severe liver failure and is often associated with significant pre-existing renal dysfunction.
出血是腹腔穿刺术公认的并发症。在肝功能衰竭患者中进行腹腔穿刺术时,由于凝血功能障碍和腹壁侧支循环,引发了特别关注。
评估腹腔穿刺术后发生出血并发症患者的临床特征。
我们回顾了1994年至2004年期间在本机构肝病科住院患者中腹腔穿刺术后发生严重出血的所有病例。
在4729例操作中识别出9例。严重出血的发生率占所有操作的0.19%,死亡率为0.016%。出血与操作者经验、国际标准化比值升高或血小板减少无关。它发生在终末期肝病模型和Child-Pugh评分较高的患者中。此外,除1例患者外,所有患者均存在一定程度的肾功能衰竭。
肝病患者腹腔穿刺术后严重出血的发生率为0.2%。它发生在严重肝功能衰竭患者中,且常与显著的既往肾功能不全相关。